Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions

BACKGROUND: The purpose of this study was to report the safety of perfluorobutane (Sonazoid) as a vascular-phase imaging agent in characterizing focal liver lesions (FLLs). MATERIALS AND METHODS: From May 2014 to April 2015, a total of 54 individuals who received Sonazoid contrast-enhanced ultrasoun...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Med Ultrasound
Главные авторы: Chou, Yi-Hong, Liang, Ja-Der, Wang, Shen-Yung, Hsu, Shih-Jer, Hu, Jui-Ting, Yang, Sien-Sing, Wang, Hsin-Kai, Lee, Tien-Ying, Tiu, Chui-Mei
Формат: Artigo
Язык:Inglês
Опубликовано: Wolters Kluwer - Medknow 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607878/
https://ncbi.nlm.nih.gov/pubmed/31316217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/JMU.JMU_44_19
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы